Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Investor Relations


Cowen 42nd Annual Healthcare Conference
 March 7, 2022 -
March 9, 2022

Cardiff Oncology management will participate in a panel discussion and one-on-one investor meetings at Cowen's 42nd Annual Healthcare Conference taking place virtually March 7-9.

To listen to the GI/GU Oncology Panel please click on the below link to register.  A replay of the panel discussion featuring CEO Dr. Mark Erlander will be archived and available on our website for 30 days following the conference.